Advances in Medical Management of Overactive Bladder
- 30 June 2003
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (6) , 681-683
- https://doi.org/10.4065/78.6.681
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA TrialMayo Clinic Proceedings, 2003
- Pharmacokinetics, Metabolism, and Saliva Output During Transdermal and Extended-Release Oral Oxybutynin Administration in Healthy SubjectsMayo Clinic Proceedings, 2003
- Muscarinic receptor subtypes and management of the overactive bladderUrology, 2002
- The minor population of M3‐receptors mediate contraction of human detrusor muscle in vitroJournal of Autonomic Pharmacology, 2001
- Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO‐K1 cellsBritish Journal of Pharmacology, 1999
- Economic costs of urinary incontinence in 1995Urology, 1998